Skip to main content
Clinical Trials/NCT01855581
NCT01855581UnknownNot Applicable

The Incidence and Nature of Adverse Events During Pediatric Sedation for MRI/CT in One Korean University Hospital: Retrospective Study

Yonsei University1 site in 1 country3,739 target enrollmentStarted: November 2012Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Enrollment
3,739
Locations
1
Primary Endpoint
Frequency of Adverse Events

Study Overview

Brief Summary

Sedation and anesthesia for diagnostic imaging represents a rapidly growing field of practice, especially in children. Propofol is the most common sedative drug administered for MRI/CT. However, this drug is associated with adverse events, including pulmonary complications, and there has been no report on these complications in Korea.

The investigators reviewed 3739 charts of pediatric patients sedated for MRI/CT between January and November 2012.

In this study, the investigators will report the nature and frequency of adverse events associated with sedation for MRI/CT between January and November 2012.

Study Design

Study Type
Observational
Time Perspective
Retrospective

Eligibility Criteria

Ages
— to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Requiring sedation for MRI/CT, aged 0- 18 years

Exclusion Criteria

  • Not provided

Arms & Interventions

sedation group

Children requiring sedation for MRI/CT

Intervention: pediatric sedation (propofol, ketamine, etc) (Drug)

Outcomes

Primary Outcomes

Frequency of Adverse Events

Time Frame: 24 hours

The investigators will review all adverse events that are associated with pediatric sedation for MRI/CT

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials